| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ENTELLUS MEDICAL INC | 3,489,533 | 66,198,000 | 55.74% | ||
| 2 | KALVISTA PHARMACEUTICALS INC | 2,579,490 | 18,237,000 | 15.36% | ||
| 3 | OCULAR THERAPEUTIX INC | 1,605,207 | 13,436,000 | 11.31% | ||
| 4 | Catabasis Pharmaceuticals Inc | 2,857,667 | 10,315,000 | 8.69% | ||
| 5 | TRANSENTERIX INC | 7,546,692 | 9,811,000 | 8.26% | ||
| 6 | LOMBARD MEDICAL INC | 1,275,779 | 765,000 | 0.64% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-000924, filed 2017.02.07).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
